90-day dapivirine ring for women's HIV prevention passes its first test in Phase I study
If approved, the monthly dapivirine vaginal ring would be the first biomedical HIV prevention method designed specifically for cisgender women, as well as the first long-acting method. Looking to the future, researchers from ...